R.H. Bluestein & Co’s iShares Core S&P US Value ETF IUSV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.51M Buy
56,006
+3,522
+7% +$243K 0.22% 53
2022
Q2
$3.51M Sell
52,484
-2,553
-5% -$183K 0.22% 53
2022
Q1
$4.18M Buy
55,037
+2,723
+5% +$204K 0.18% 53
2021
Q4
$3.99M Buy
52,314
+3,701
+8% +$275K 0.14% 49
2021
Q3
$3.45M Buy
48,613
+3,024
+7% +$220K 0.14% 49
2021
Q2
$3.28M Buy
45,589
+9,941
+28% +$715K 0.13% 55
2021
Q1
$2.46M Buy
35,648
+7,662
+27% +$503K 0.1% 56
2020
Q4
$1.74M Buy
27,986
+7,580
+37% +$444K 0.08% 75
2020
Q3
$1.11M Buy
20,406
+629
+3% +$34.4K 0.06% 87
2020
Q2
$1.03M Sell
19,777
-3,803
-16% -$194K 0.06% 90
2020
Q1
$1.09M Sell
23,580
-1,402
-6% -$80.6K 0.09% 71
2019
Q4
$1.57M Buy
24,982
+12,884
+106% +$777K 0.08% 56
2019
Q3
$699K Buy
+12,098
New +$688K 0.04% 106

Other funds holding IUSV

R.H. Bluestein & Co's IUSV Position: Q3 2022 in Review

R.H. Bluestein & Co increased its iShares Core S&P US Value ETF (IUSV) stake by 6.7% in Q3 2022, buying an estimated $243K and bringing the position to 56,006 shares worth $3.51M. The position accounts for 0.22% of the portfolio, ranked #53.

R.H. Bluestein & Co first reported a position in IUSV in Q3 2019 and has held it in 13 quarters since. The position peaked at $4.18M in Q1 2022. 478 funds tracked by Wall St. Rank hold IUSV as of Q3 2022.

  • R.H. Bluestein & Co held 56,006 shares of iShares Core S&P US Value ETF worth $3.51M as of Q3 2022.
  • R.H. Bluestein & Co bought 3,522 iShares Core S&P US Value ETF shares in Q3 2022, an estimated $243K.
  • iShares Core S&P US Value ETF made up 0.22% of R.H. Bluestein & Co's portfolio in Q3 2022, its #53 holding.
  • R.H. Bluestein & Co first reported a position in iShares Core S&P US Value ETF in Q3 2019 and has held it in 13 quarters since.
  • R.H. Bluestein & Co's iShares Core S&P US Value ETF position peaked at $4.18M in Q1 2022.
  • 478 funds tracked by Wall St. Rank held iShares Core S&P US Value ETF as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.